Literature DB >> 32081962

Perioperative cetuximab plus chemotherapy reduces overall survival in metastatic disease.

Iain Dickson1.   

Abstract

Entities:  

Year:  2020        PMID: 32081962     DOI: 10.1038/s41575-020-0277-9

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial.

Authors:  John A Bridgewater; Siân A Pugh; Tom Maishman; Zina Eminton; Jane Mellor; Amy Whitehead; Louise Stanton; Michael Radford; Andrea Corkhill; Gareth O Griffiths; Stephen Falk; Juan W Valle; Derek O'Reilly; Ajith K Siriwardena; Joanne Hornbuckle; Myrddin Rees; Timothy J Iveson; Tamas Hickish; O James Garden; David Cunningham; Timothy S Maughan; John N Primrose
Journal:  Lancet Oncol       Date:  2020-01-31       Impact factor: 41.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.